Eric S. Lander

President & Director at The Broad Institute, Inc.

Eric S. Lander

Eric S. Lander

President & Director at The Broad Institute, Inc.

Overview
Career Highlights

The Broad Institute, Inc.
Neon Therapeutics, Inc.
Codiak Biosciences, Inc.

RelSci Relationships

4774

Number of Boards

16

Birthday

02/03/1957 - Brooklyn, New York

Age

63

Number of Awards

7

Relationships
RelSci Relationships are individuals Eric S. Lander likely has professional access to. A relationship does not necessarily indicate a personal connection.

President Emeritus at California Institute of Technology

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

President at Society For Neuroscience

Relationship likelihood: Strong

Co-Founder at Eli & Edythe Broad Foundation

Relationship likelihood: Strong

Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Co-Founder at The Schmidt Family Foundation

Relationship likelihood: Strong

Founder at DNX Corporation

Relationship likelihood: Strong

Former Chief Executive Officer at Genentech, Inc.

Relationship likelihood: Strong

Paths to Eric S. Lander
Potential Connections via
Relationship Science
You
Eric S. Lander
President & Director at The Broad Institute, Inc.
Family Members
Sibling

The Santa Fe Institute is a private, not-for-profit, independent research and education center, founded in 1984, where leading scientists grapple with some of the most compelling and complex problems of our time. Researchers come to the Santa Fe Institute from universities, government agencies, research institutes, and private industry to collaborate across disciplines, merging ideas and principles of many fields -- from physics, mathematics, and biology to the social sciences and the humanities -- in pursuit of creative insights that improve our world. The Institute's scientific and educational missions are supported by philanthropic individuals and foundations, forward-thinking partner companies, and government science agencies

Education
D.Phil Mathematics
Class of 1981

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

BA in Mathematics
Class of 1978

Princeton University is a vibrant community of scholarship and learning that stands in the nation's service and in the service of all nations. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the humanities, social sciences, natural sciences and engineering. As a world-renowned research university, Princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding. At the same time, Princeton is distinctive among research universities in its commitment to undergraduate teaching. Today, more than 1,100 faculty members instruct approximately 5,000 undergraduate students and 2,500 graduate students. The University's generous financial aid program ensures that talented students from all economic backgrounds can afford a Princeton education.

Attendee

Stuyvesant High School has been a symbol of excellence in education for over a century. Our mission is to continue and enhance that commitment by providing an environment which will nurture and enhance the special academic talents of the students admitted to Stuyvesant. The educational heritage of Stuyvesant is deeply rooted in the tradition of Science, Mathematics and Technology. This has been the foundation of our educational success and must remain the cornerstone of our educational program. Within this context, the goal of this institution is to instill the intellectual, moral and humanistic values necessary for each child to achieve his/her maximum potential as a student and as a caring citizen of the world.

Memberships
Member
2013 - Current
Member
1999 - Prior

The Institute of Medicine (IOM) is an independent, nonprofit organization that works outside of government to provide unbiased and authoritative advice to decision makers and the public. Established in 1970, the IOM is the health arm of the National Academy of Sciences, which was chartered under President Abraham Lincoln in 1863. Nearly 150 years later, the National Academy of Sciences has expanded into what is collectively known as the National Academies, which comprises the National Academy of Sciences, the National Academy of Engineering, the National Research Council, and the IOM.

Member
1997 - Prior

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Career History
Scientific Founder
2013 - Current

Neon Therapeutics, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.

President & Director
2003 - Current

The Broad Institute evolved from a decade of informal and successful research collaborations among scientists in the MIT and Harvard communities. In 1990, the Whitehead Institute/MIT Center for Genome Research (WICGR) was founded, and it soon became an international leader in the field of genomics and a flagship of the Human Genome Project. As early as 1995, WICGR scientists recognized the need to bring the power of genomics to the understanding of human disease. It launched pilot projects in genomic medicine, forming an unofficial collaborative network among scientists from across MIT and Harvard who pioneered new approaches to cancer and human genetics. In parallel, Harvard Medical School-based scientists established the Institute of Chemistry and Cell Biology (ICCB) in 1998, to facilitate the pursuit of chemical genetics as an academic discipline and a tool to further understand human biology and disease. In 2002, the ICCB was awarded an Initiative for Chemical Genetics (ICG) grant from the National Cancer Institute, and its successful Investigator-Initiated Screening Program facilitated small molecule screening projects for more than 80 research groups worldwide. These projects demonstrated the power of enabling scientists to collaborate to tackle the major challenges in molecular medicine. It was clear that a new type of formal organization was required — open, collaborative, interdisciplinary, and able to organize projects at any scale. In addition, it was important that the complementary expertise of the genomic scientists and the chemical biologists across MIT and Harvard be brought together in one place to drive the transformation of medicine with molecular knowledge. Discussions in 2002-2003 among Eli and Edythe Broad, MIT, Harvard and its affiliated hospitals, and the Whitehead Institute shaped the vision for this new institute. The extraordinary generosity of Eli and Edythe Broad, through their founding gift of $100 million (later doubled to $200 million) made it possible to formally announce the new institute in June 2003 and to launch it in May 2004. Less than four years after its launch, the Broads gave an unprecedented gift of $400 million in September 2008 to permanently endow the institute, providing long-term sustainability for its unique model of collaborative, inter-institutional research.

Professor of Biology
Current

The School of Science provides each of its undergraduates with an understanding of the basic elements of biology, chemistry, mathematics and physics. Some of our most famous faculty members, even a few with Nobel Prizes, are also some of the best teachers of our first-year subjects. In addition to being prepared to enter research, industry, or academia, our students—graduate and undergraduate—often pursue medical, law, or business degrees and are uniquely prepared to make creative contributions to the world.

Boards & Committees
Member, Scientific Advisory Board
Current

Impresa focuses on early-stage investments in start-up companies across US and International portfolio companies. There fund focuses on companies operating in the fields of biopharmaceutical, medical technology & healthcare IT and services.There funds are larger and more global. In the US and Europe, they are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, there sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai with over $2 trillion in assets under management.

Director
2001 - 2006
Member, Selection Committee
2013 - Current

The Breakthrough Prize in Life Sciences is founded by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg and Priscilla Chan, and Yuri Milner to recognize excellence in research aimed at curing intractable diseases and extending human life. The prize is administered by the Breakthrough Prize in Life Sciences Foundation, a not-for-profit corporation dedicated to advancing breakthrough research, celebrating scientists and generating excitement about the pursuit of science as a career.

Political Donations
$15K
2012

Former President of United States

$250
2011

Former President, Chief Executive Officer & Director at New Economics Institute

$2,500
2011

Former President of United States

Investments
Details Hidden

Neon Therapeutics, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.

Details Hidden

Codiak BioSciences, Inc. develops exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The company develops engEx Platform, proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. The company was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.

Details Hidden

Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA™ (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma (FL) after at least two prior systemic therapies. The indication in FL is approved under accelerated approval based on overall response rate. In addition, it is developing the focal adhesion kinase inhibitor defactinib, which is being evaluated in three separate clinical collaborations in combination with immunotherapeutic agents for the treatment of various different cancer types, including pancreatic cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and mesothelioma. Verastem, Inc. has collaboration agreements with Yakult Honsha Co., Ltd., CSPS Pharmaceutical Group Limited and The Leukemia & Lymphoma Society. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Advisors
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Awards & Honors
2013
Breakthrough Prize in Life Sciences
2004
TIME - 100 Most Influential People in the World
1987
MacArthur Fellowship
Events
Attendee
Sitges, Spain
2010 Bilderberg Meeting

The 58th Bilderberg Meeting will be held in Sitges, Spain 3 - 6 June 2010. The Conference will deal mainly with Financial Reform, Security, Cyber Technology, Energy, Pakistan, Afghanistan, World Food Problem, Global Cooling, Social Networking, Medical Science, EU-US relations. Approximately 130 participants will attend of whom about two-thirds come from Europe and the balance from North America. About one-third is from government and politics, and two-thirds are from finance, industry, labor, education, and communications. The meeting is private in order to encourage frank and open discussion. Bilderberg takes its name from the hotel in Holland, where the first meeting took place in May 1954. That pioneering meeting grew out of the concern expressed by leading citizens on both sides of the Atlantic that Western Europe and North America were not working together as closely as they should on common problems of critical importance. It was felt that regular, off-the-record discussions would help create a better understanding of the complex forces and major trends affecting Western nations in the difficult post-war period. The Cold War has now ended. But in practically all respects there are more, not fewer, common problems - from trade to jobs, from monetary policy to investment, from ecological challenges to the task of promoting international security. It is hard to think of any major issue in either Europe or North America whose unilateral solution would not have repercussions for the other. Thus the concept of a European-American forum has not been overtaken by time. The dialogue between these two regions is still - even increasingly - critical. What is unique about Bilderberg as a forum is the broad cross-section of leading citizens that are assembled for nearly three days of informal and off-the-record discussion about topics of current concern especially in the fields of foreign affairs and the international economy; the strong feeling among participants that in view of the differing attitudes and experiences of the Western nations, there remains a clear need to further develop an understanding in which these concerns can be accommodated; the privacy of the meetings, which has no purpose other than to allow participants to speak their minds openly and freely. In short, Bilderberg is a small, flexible, informal and off-the-record international forum in which different viewpoints can be expressed and mutual understanding enhanced. Bilderberg's only activity is its annual Conference. At the meetings, no resolutions are proposed, no votes taken, and no policy statements issued. Since 1954, fifty-seven conferences have been held. The names of the participants are made available to the press. Participants are chosen for their experience, their knowledge, and their standing; all participants attend Bilderberg in a private and not an official capacity.

Speaker
Aspen, CO, United States
2009 Aspen Ideas Festival

Aspen Ideas Festival, presented by the Aspen Institute and The Atlantic, continues to broaden its reach and engage with more people than ever before on ideas that matter. A major focus throughout the Festival, which opens today, is increasing live and on-demand video opportunities for online viewers around the world.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eric S. Lander. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eric S. Lander's profile does not indicate a business or promotional relationship of any kind between RelSci and Eric S. Lander.